QIAGEN NV
QGENF
QGENF was delisted on the 14th of February, 2005.
210 hedge funds and large institutions have $3.9B invested in QIAGEN NV in 2016 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 69 increasing their positions, 68 reducing their positions, and 17 closing their positions.
185% more call options, than puts
Call options by funds: $2.63M | Put options by funds: $923K
135% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 17
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
29% more capital invested
Capital invested by funds: $3.03B → $3.9B (+$879M)
12% more funds holding
Funds holding: 188 → 210 (+22)
1% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 68
Top Buyers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$108M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$58M |
| 3 |
SIG
Senator Investment Group
New York
|
+$27.4M |
| 4 |
Millennium Management
New York
|
+$20.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$17.5M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$35.2M |
| 2 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
-$31.9M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$25.4M |
| 4 |
Harris Associates
Chicago,
Illinois
|
-$22.9M |
| 5 |
MNA
Manning & Napier Advisors
Fairport,
New York
|
-$22.4M |
QGENF Hedge Fund Activity: Q3 2016 in Review
210 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in QIAGEN NV (QGENF) for Q3 2016, worth a combined $3.9B — up 29% from $3.03B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new QGENF positions and 17 closed out — a net gain of 23 holders — while 69 added to existing stakes and 68 trimmed.
The largest buyer was Deutsche Bank, adding an estimated $108M. The largest seller was Citadel Advisors, cutting an estimated $35.2M.
- 210 institutional investors held QIAGEN NV (QGENF) as of Q3 2016, up from 188 in Q2 2016.
- Funds reported $3.9B of QIAGEN NV stock for Q3 2016, up 29% quarter-over-quarter.
- 40 funds opened new QIAGEN NV positions in Q3 2016 and 17 closed out, a net change of +23 holders.
- The largest QIAGEN NV buyer in Q3 2016 was Deutsche Bank, an estimated $108M added.
- The largest QIAGEN NV seller in Q3 2016 was Citadel Advisors, an estimated $35.2M sold.
Based on aggregated 13F filings for Q3 2016.